{"id":131058,"date":"2026-09-30T09:14:38","date_gmt":"2026-09-30T16:14:38","guid":{"rendered":"https:\/\/fomatmedical.com\/?p=131058"},"modified":"2026-09-30T09:57:03","modified_gmt":"2026-09-30T16:57:03","slug":"endocrinology-clinical-trials-nc","status":"publish","type":"post","link":"https:\/\/fomatmedical.com\/es\/company-updates\/endocrinology-clinical-trials-nc\/","title":{"rendered":"Ya est\u00e1n disponibles los ensayos cl\u00ednicos de endocrinolog\u00eda para pacientes en Raleigh"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Endocrinology clinical trials have historically been hard to access for patients managing diabetes, thyroid disease, or another endocrine condition. Taking part has usually meant being sent somewhere unfamiliar: a different doctor, a different building, a different relationship to rebuild from scratch. That barrier keeps a lot of patients who would otherwise be interested in research from ever taking the step.<\/p>

That is exactly what is changing in Raleigh. Creedmoor Centre Endocrinology has partnered with FOMAT, a national research network, to bring clinical trials directly into the practice, removing the barrier of being referred somewhere unfamiliar.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Why Endocrinology Clinical Trials Are Hard to Access<\/h2>

Endocrine and metabolic conditions, including diabetes, thyroid disorders, and osteoporosis, affect a huge share of the population, according to the CDC<\/a>, yet the number of practices equipped to run clinical trials alongside everyday patient care remains small. Most endocrinology clinics are built for treatment, not research infrastructure, which means promising new therapies often reach patients more slowly than they could.<\/p>

Closing that gap requires more than funding. It requires pairing clinical expertise with the operational systems, regulatory support, and study coordination that research demands, without asking physicians to choose between running a practice and running a trial.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t
\n\t\t\t

\n\t\t\t\tPatients get to stay with the physician and care team they already know, instead of being referred to an unfamiliar research site.\t\t\t<\/p>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Creedmoor\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Creedmoor Centre Endocrinology Joins FOMAT Research Network<\/h2>

Founded in 2008 and led by Dr. Julia Warren-Ulanch since 2013, Creedmoor Centre Endocrinology is now part of a national network built specifically to embed clinical research inside community practices.<\/p>

For patients, the practical effect is straightforward. Anyone managing diabetes, a thyroid disorder, or another metabolic condition through Creedmoor Centre Endocrinology may now have access to clinical trials evaluating new treatments, often well before those treatments become widely available, all delivered by the same team that already manages their day to day care.<\/p>

That continuity matters. Clinical trial participation typically comes with added monitoring and support on top of standard treatment, and receiving that from a familiar care team, rather than an outside research site, tends to feel far less disruptive for patients already managing a chronic condition.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Curious about the full details of this partnership?<\/strong> Our official announcement covers the practice’s background, the physicians involved, and what this means for the broader network.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\n
\n
\n Read the Full Announcement <\/span><\/span>\n <\/a>\n <\/div>\n <\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Growing by Depth, Not Just by Map<\/h2>

This addition also reflects a broader shift in how FOMAT approaches growth. Rather than measuring progress purely by the number of states or cities covered, the focus has increasingly turned toward the kind of clinical expertise each new site brings with it. A site that specializes in endocrinology adds something a general practice cannot: a deeper pipeline of patients who fit the specific criteria that endocrinology clinical trials require, and physicians who already understand the nuances of those conditions.<\/p>

What This Means Going Forward<\/h2>

With Creedmoor Centre Endocrinology now part of the network, endocrinology joins a growing list of therapeutic areas where community based practices are taking on a larger role in clinical research. For patients, that could mean shorter waitlists for trial eligibility screening, more localized study options, and continued access to new treatments as they move through development.<\/p>

For the practice itself, the shift opens the door to participate in a wider range of studies over time, expanding what it can offer patients without changing how care is delivered day to day. Learn more about FOMAT<\/a> and its network of clinical research sites.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Frequently Asked Questions<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t
What is an Embedded Research Organization (ERO)? <\/div><\/span>\n\t\t\t\t\t\t\t\t\t<\/summary>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

An ERO gives a network of local practices, like this one, centralized support for running clinical trials. A single team coordinates the regulatory approvals, study start up, and quality oversight behind the scenes, so the physician office can offer research to patients without changing how the practice itself operates.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t

\n\t\t\t\t\n\t\t\t\t\t
What conditions does Creedmoor Centre Endocrinology focus on? <\/div><\/span>\n\t\t\t\t\t\t\t\t\t<\/summary>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The practice specializes in endocrine and metabolic conditions, including diabetes, thyroid disorders, and osteoporosis.<\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t

\n\t\t\t\t\n\t\t\t\t\t
Do patients have to switch doctors to join a trial? <\/div><\/span>\n\t\t\t\t\t\t\t\t\t<\/summary>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

No. One of the main advantages of this model is that patients can participate in endocrinology clinical trials through the same physician and care team they already see for regular treatment.<\/p><\/div>

\u00a0<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t
How many sites are in the network now? <\/div><\/span>\n\t\t\t\t\t\t\t\t\t<\/summary>\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

This addition brings the national network to more than 40 investigator sites across the United States.<\/p><\/div><\/article>

\u00a0<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t